Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Familial Dyslipidemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02957682
What this trial is testing

Evaluating Effect of the Study Drug Praluent (Alirocumab) on Neurocognitive Function When Compared to Placebo

Who this might be right for
Hypercholesterolemia
Regeneron Pharmaceuticals 2,176
Not applicableStudy completedNCT00365235
What this trial is testing

Understanding the Genetic Basis of Familial Combined Hyperlipidemia in Mexican Individuals

Who this might be right for
Hyperlipidemia, Familial CombinedCoronary Disease
University of California, Los Angeles 998
Early research (Phase 1)Ended earlyNCT01350960
What this trial is testing

Multiple Ascending Dose Study of SPC5001 in Treatment of Healthy Subjects and Subjects With FH

Who this might be right for
Hypercholesterolemia
Santaris Pharma A/S 24
Not applicableLooking for participantsNCT07086989
What this trial is testing

Cardiovascular Risk in Children With Chronic Conditions Study

Who this might be right for
Kidney TransplantFamilial HypercholesterolaemiaType 1 Diabetes Mellitus (T1DM)+22 more
Semmelweis University 300
Not applicableStudy completedNCT04494464
What this trial is testing

Treatment Rates and Compliance to Treatment in Patients With Familial Hypercholesterolemia

Who this might be right for
Familial Hypercholesterolemia
Ankara Yildirim Beyazıt University 367
Testing effectiveness (Phase 2)Study completedNCT03060577
What this trial is testing

An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol

Who this might be right for
Atherosclerotic Cardiovascular DiseaseSymptomatic AtherosclerosisType2 Diabetes+1 more
Novartis Pharmaceuticals 382
Not applicableUnknownNCT03152656
What this trial is testing

A Registration Study for Familial Hypercholesterolemia in Taiwan

Who this might be right for
Familial Hypercholesterolemia
National Taiwan University Hospital 1,000
Not applicableNot Yet RecruitingNCT05825612
What this trial is testing

EPIRUS FH Reverse Cascade Screening

Who this might be right for
Familial Hypercholesterolemia
Hellenic Atherosclerosis Society 1,000
Not applicableStudy completedNCT02130505
What this trial is testing

Inflammatory Aspects of Glucose in Hyperlipidemia and Diabetes

Who this might be right for
AtherosclerosisLeukocyte Activation DisorderType 2 Diabetes Mellitus+1 more
Sint Franciscus Gasthuis 51
Large-scale testing (Phase 3)Study completedNCT01514461
What this trial is testing

A Randomized, Double-blind, Placebo Controlled Study to Assess Efficacy, Safety and Tolerability of LCQ908 in Subjects With Familial Chylomicronemia Syndrome

Who this might be right for
Familial Chylomicronemia Syndrome (FCS)
Novartis Pharmaceuticals 45
Large-scale testing (Phase 3)Looking for participantsNCT07614958
What this trial is testing

Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipidemia in Adults With Primary Non-familial Hypercholesterolemia or Mixed Dyslipidemia at High to Very High Cardiovascular Risk, During a Treatment Period of Approximately 84 Days

Who this might be right for
Mixed DyslipidemiaHypercholesterolaemia
A. Menarini International Licensing S.A. 426
Not applicableEnded earlyNCT02345421
What this trial is testing

Identify and Characterize LAL-D Patients in High-risk Populations

Who this might be right for
Lysosomal Acid Lipase Deficiency
Alexion Pharmaceuticals, Inc. 640
Not applicableLooking for participantsNCT05693701
What this trial is testing

Multicomponent Intervention Study- Blood Donors With High Cholesterol

Who this might be right for
Lipid Metabolism Disorder
University of Texas Southwestern Medical Center 100
Large-scale testing (Phase 3)UnknownNCT04948008
What this trial is testing

Evaluate the Efficacy and Safety of IBI306 in Subjects With Homozygous Familial Hypercholesterolemia

Who this might be right for
Familial Hypercholesterolemia - HomozygousLipid Metabolism DisordersProprotein Convertase Subtilisin/Kexin 9
Shenzhen People's Hospital 8
Not applicableStudy completedNCT03018678
What this trial is testing

Screening Protocol for a Gene Therapy Trial in Subjects With Homozygous Familial Hypercholesterolemia

Who this might be right for
Hypercholesterolemia, Familial
University of Pennsylvania 21
Large-scale testing (Phase 3)Study completedNCT02173158
What this trial is testing

Efficacy and Safety of Lomitapide in Japanese Patients With HoFH on Concurrent Lipid-Lowering Therapy

Who this might be right for
Familial Hypercholesterolemia - Homozygous
Aegerion Pharmaceuticals, Inc. 9
Not applicableStudy completedNCT03293810
What this trial is testing

Glybera Registry, Lipoprotein Lipase Deficient (LPLD) Patients

Who this might be right for
Lipoprotein Lipase DeficiencyFamilial Hyperlipoproteinemia Type 1Familial Hyperchylomicronemia
UniQure Biopharma B.V. 16
Large-scale testing (Phase 3)Study completedNCT03399786
What this trial is testing

Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia

Who this might be right for
Homozygous Familial Hypercholesterolemia
Regeneron Pharmaceuticals 65
Large-scale testing (Phase 3)Study completedNCT00654446
What this trial is testing

IIIb 6 Week Open Label Multicentre Rosuvastatin & Simvastatin

Who this might be right for
Fredrickson Type IIa & Type IIb Dyslipidaemia
AstraZeneca 442
Early research (Phase 1)Looking for participantsNCT06451770
What this trial is testing

Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia

Who this might be right for
HypercholesterolemiaHypertriglyceridemiaRefractory Hyperlipidemia
Verve Therapeutics, Inc. 36
Next Page